Search for: "Association for Molecular Pathology v. Myriad Genetics, Inc." Results 61 - 80 of 187
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jun 2013, 10:29 am by Jim Lennon & Greg Brodzik
Widely divergent views have formed in the wake of the Supreme Court’s decision in Association of Molecular Pathology v. [read post]
5 Sep 2014, 9:38 am by Gene Quinn
Supreme Court should have reached in Association of Molecular Pathology v. [read post]
12 Feb 2013, 9:59 pm by Patent Docs
By Donald Zuhn -- In an amicus brief filed last month in Association for Molecular Pathology v. [read post]
18 Jun 2014, 8:50 am by Doug Bucklin
The Supreme Court decision in Association of Molecular Pathology, et al. v. [read post]
29 Mar 2010, 7:19 pm by Omar Ha-Redeye
A New York court has struck the patents held by Myriad Genetics Inc. for BRCA1 and BRCA2 which have been linked to breast and ovarian cancer in Association for Molecular Pathology, et al. v. [read post]
2 Apr 2013, 9:59 pm by Patent Docs
According to the two researchers, the Association for Molecular Pathology v. [read post]
19 Jun 2013, 6:12 am by RatnerPrestia
Supreme Court’s June 13, 2013 decision in Association for Molecular Pathology v Myriad Genetics affirms the patent eligibility of DNA and its uses, but holds that finding “an important and useful gene and separating that gene from its surrounding genetic material is not an act of invention. [read post]
9 Mar 2021, 9:21 pm by Patent Docs
Prometheus Laboratories, Inc. decisions (as well as Association for Molecular Pathology v. [read post]
3 Jun 2013, 6:17 am by Marissa Miller
Briefly: MSNBC’s Geoffrey Cowley previews the Court’s upcoming decision in Association for Molecular Pathology v. [read post]
26 Jul 2014, 9:14 pm by Mark Summerfield
  The Supreme Court considered gene patents in Association for Molecular Pathology v. [read post]
5 Sep 2014, 9:41 pm by Mark Summerfield
D'Arcy v Myriad Genetics Inc [2014] FCAFC 115 (5 September 2014)A special expanded bench of five judges of the Federal Court of Australia has thumbed its collective nose at the US Supreme Court, finding that isolated genetic material is patent-eligible in Australia, and that (‘with respect’, of course) the emphasis of the US’ top court (in Association for Molecular Pathology v Myriad… [read post]
17 Jun 2013, 5:46 am by Marissa Miller
This weekend’s coverage highlights the Term’s most anticipated decisions, including last Thursday’s opinion in Association for Molecular Pathology v. [read post]